Skip to main content
. 2018 Jul 10;119(3):323–329. doi: 10.1038/s41416-018-0174-y

Fig. 2.

Fig. 2

Combined nuclear pERK/p-p38 score differentially stratifies BRAF mutant CRC patient survival in MMR-competent and MMR-deficient patients (n = 165). Kaplan–Meier curves showing association between the combined nuclear pERK/p-p38 score and CSS in BRAF mutant patients with (a) MMR-competent or (b) MMR-deficient CRC